Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1161/STROKEAHA.116.014702 | DOI Listing |
Eur Child Adolesc Psychiatry
August 2024
Department of Psychiatry and Behavioral Sciences, Norton College of Medicine at SUNY Upstate Medical University, Syracuse, NY, USA.
Eur Child Adolesc Psychiatry
May 2024
Department of Psychiatry and Behavioral Sciences, Norton College of Medicine at SUNY Upstate Medical University, Syracuse, NY, USA.
Am J Emerg Med
June 2024
Department of Pharmacotherapy, University of Utah College of Pharmacy, 30 South 2000 East, Salt Lake City, UT 84112, United States of America. Electronic address:
J Am Acad Child Adolesc Psychiatry
July 2024
Norton College of Medicine at SUNY Upstate Medical University, Syracuse, New York.
Despite decades of clinical use and a large body of evidence, the WHO continues to exclude methylphenidate for attention-deficit/hyperactivity disorder (ADHD) from its EML. The exclusion of methylphenidate has dire implications for millions of individuals with ADHD worldwide, especially those living in low and low-middle income countries (LMIC), where governmental decisions to make medicines available are contingent on EML listing.
View Article and Find Full Text PDFLancet Psychiatry
February 2024
Department of Psychiatry and Behavioral Sciences, Norton College of Medicine at SUNY Upstate Medical University, Syracuse, NY, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!